I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 17 studies | 20% ± 5% | |
| oligodendrocyte | 11 studies | 28% ± 12% | |
| CD16-positive, CD56-dim natural killer cell, human | 9 studies | 22% ± 6% | |
| endothelial cell | 9 studies | 26% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 7 studies | 19% ± 3% | |
| astrocyte | 6 studies | 29% ± 11% | |
| glutamatergic neuron | 5 studies | 42% ± 23% | |
| epithelial cell | 5 studies | 32% ± 8% | |
| macrophage | 5 studies | 23% ± 6% | |
| fibroblast | 5 studies | 20% ± 6% | |
| oligodendrocyte precursor cell | 5 studies | 31% ± 12% | |
| B cell | 4 studies | 20% ± 3% | |
| microglial cell | 4 studies | 22% ± 6% | |
| ciliated cell | 4 studies | 18% ± 3% | |
| GABAergic neuron | 4 studies | 38% ± 17% | |
| CD8-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| interneuron | 4 studies | 31% ± 22% | |
| CD4-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| mature NK T cell | 3 studies | 18% ± 2% | |
| non-classical monocyte | 3 studies | 23% ± 4% | |
| naive B cell | 3 studies | 16% ± 0% | |
| adipocyte | 3 studies | 20% ± 5% | |
| lymphocyte | 3 studies | 21% ± 3% | |
| regulatory T cell | 3 studies | 16% ± 1% | |
| type I pneumocyte | 3 studies | 19% ± 2% | |
| dendritic cell | 3 studies | 29% ± 9% | |
| abnormal cell | 3 studies | 23% ± 7% | |
| pericyte | 3 studies | 19% ± 4% | |
| smooth muscle cell | 3 studies | 16% ± 1% | |
| basal cell | 3 studies | 31% ± 10% | |
| goblet cell | 3 studies | 29% ± 13% | |
| transit amplifying cell | 3 studies | 29% ± 15% | |
| neuron | 3 studies | 35% ± 10% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 2% |
